pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Immunotherapy and reparative therapy as a method of improving the results of surgical treatment of patients with pulmonary tuberculosis

    Редакция | 2016, Drugs and equipment, Practical medicine 03 (16) Allergology. Immunology. Pulmonology | 30 мая, 2016

    V.T. CHUBARYAN1, E.I. MITCHENKO1, I.A. POLOZYUKOV2, D.S. DUDNICHENKO2

    1Rostov State Medical University, 29 Nakhichevanskiy alley, Rostov-on-Don, Russian Federation, 344022

    2Specialized tuberculosis hospital, 24 Orskaya Str., Rostov-on-Don, Russian Federation, 344065

     

    Chubaryan V.T. ― D. Med. Sc., Pofessor, Head of the Department of Phthisiology and Pulmonology, tel. (863) 223-36-04, e-mail: chubar88@yandex.ru

    Mitchenko E.I. ― assistant of the Department of Phthisiology and Pulmonology, tel. +8-904-500-49-41, e-mail: ugregion@list.ru

    Polozyukov I.A. ― Head of Surgical Department, tel. +7-918-554-58-61, e-mail: i.polozukoff@yandex.ru

    Dudnichenko D.S. ― thoracic surgeon, tel. +7-905-455-12-43, e-mail: krokodil00@list.ru

    Krotov Yu.P. ― thoracic surgeon, Deputy Chief Physician, tel. +7-904-340-22-82, e-mail: ypk@mail.ru

    The article presents the results of a comparative study of the clinical assessment of reparant, cytoprotector and immunocorrector of sodium deoxyribonucleate (Derinat) in the postoperative period of surgical treatment of patients with pulmonary tuberculosis. 37 patients of the main group received Derinat in addition to standard therapy in the postoperative period ― 15 mg/ml intramuscular injection with 5 ml of solution, 5 injections per course. In the comparison group were observed 42 patients who did not receive Derinat. Clinical and laboratory parameters of patients in the postoperative period, the incidence of postoperative complications, relapse and recurrence of the disease in a prospective observation for 6-12 months were estimated. The inclusion of Derinat, solution for intramuscular injection of 15 mg/ml, in the treatment plan helped to reduce the number of complications in the early and deferred postoperative period, shorten the duration of hospitalization, step up the recovery of protein-synthetic function and reactivity of the organism, LII, parameters of hemo- and leukogram.

    Key words: pulmonary tuberculosis, treatment, sodium deoxyribonucleate, Derinat, treatment efficacy.

     

    Метки: D.S. DUDNICHENKO, Derinat, E.I. MITCHENKO, I.A. POLOZYUKOV, Practical medicine 03 (16) Allergology. Immunology. Pulmonology, pulmonary tuberculosis, sodium deoxyribonucleate, treatment, treatment efficacy, V.T. CHUBARYAN

    ‹ Comparison study between MAST-CLA and OPTIGEN Evaluation of efficacy and safety of intravenous immunoglobulin IG Vena in patients with predominant antibody synthesis deficiencies ›
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©